109 related articles for article (PubMed ID: 7898935)
1. Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb.
Hiyama K; Ishioka S; Shirotani Y; Inai K; Hiyama E; Murakami I; Isobe T; Inamizu T; Yamakido M
Oncogene; 1995 Mar; 10(5):937-44. PubMed ID: 7898935
[TBL] [Abstract][Full Text] [Related]
2. Telomeric repeat-length alterations in colorectal carcinoma are associated with loss of heterozygosity and point mutation in p53 gene.
Ohki S; Onda M; Fukushima T; Takita K; Suzuki S; Hoshino M; Tsuchiya A; Abe R; Takenoshita S
Int J Mol Med; 2003 Apr; 11(4):485-90. PubMed ID: 12632102
[TBL] [Abstract][Full Text] [Related]
3. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
[TBL] [Abstract][Full Text] [Related]
4. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma.
Williams AC; Browne SJ; Yeudal WA; Paterson IC; Marshall CJ; Lane DP; Paraskeva C
Oncogene; 1993 Nov; 8(11):3063-72. PubMed ID: 8414507
[TBL] [Abstract][Full Text] [Related]
5. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS
Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205
[TBL] [Abstract][Full Text] [Related]
6. Multiple pathways to cellular senescence: role of telomerase repressors.
Oshimura M; Barrett JC
Eur J Cancer; 1997 Apr; 33(5):710-5. PubMed ID: 9282109
[TBL] [Abstract][Full Text] [Related]
7. Telomerase and human tumorigenesis.
Stewart SA; Weinberg RA
Semin Cancer Biol; 2000 Dec; 10(6):399-406. PubMed ID: 11170862
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection.
Kim JW; Lee CG; Han SM; Kim KS; Kim JO; Lee JM; Kim IK; Namkoong SE
Gynecol Oncol; 1997 Nov; 67(2):215-21. PubMed ID: 9367711
[TBL] [Abstract][Full Text] [Related]
9. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma.
Shiseki M; Kohno T; Nishikawa R; Sameshima Y; Mizoguchi H; Yokota J
Cancer Res; 1994 Nov; 54(21):5643-8. PubMed ID: 7923210
[TBL] [Abstract][Full Text] [Related]
10. A mathematical model of cellular apoptosis and senescence through the dynamics of telomere loss.
Arkus N
J Theor Biol; 2005 Jul; 235(1):13-32. PubMed ID: 15833310
[TBL] [Abstract][Full Text] [Related]
11. DNA aberrations at the retinoblastoma gene locus in human squamous cell carcinomas of the lung.
Sachse R; Murakami Y; Shiraishi M; Hayashi K; Sekiya T
Oncogene; 1994 Jan; 9(1):39-47. PubMed ID: 8302602
[TBL] [Abstract][Full Text] [Related]
12. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts.
Shay JW; Wright WE; Brasiskyte D; Van der Haegen BA
Oncogene; 1993 Jun; 8(6):1407-13. PubMed ID: 8389027
[TBL] [Abstract][Full Text] [Related]
13. [The role of telomere-binding proteins in carcinogenesis].
Aragona M; Pontoriero A; Panetta S; La Torre I; La Torre F
Minerva Med; 2000; 91(11-12):299-304. PubMed ID: 11253711
[TBL] [Abstract][Full Text] [Related]
14. Senescence and immortalization: role of telomeres and telomerase.
Shay JW; Wright WE
Carcinogenesis; 2005 May; 26(5):867-74. PubMed ID: 15471900
[TBL] [Abstract][Full Text] [Related]
15. Control of telomere length by the human telomeric protein TRF1.
van Steensel B; de Lange T
Nature; 1997 Feb; 385(6618):740-3. PubMed ID: 9034193
[TBL] [Abstract][Full Text] [Related]
16. Reduced telomeric signals and increased telomeric associations in human lung cancer cell lines undergoing p53-mediated apoptosis.
Mukhopadhyay T; Multani AS; Roth JA; Pathak S
Oncogene; 1998 Aug; 17(7):901-6. PubMed ID: 9780006
[TBL] [Abstract][Full Text] [Related]
17. [Genetic abnormalities in lung cancer and their prognostic implications].
Mitsudomi T; Takahashi T
Gan To Kagaku Ryoho; 1996 Jul; 23(8):990-6. PubMed ID: 8687234
[TBL] [Abstract][Full Text] [Related]
18. Telomere-driven karyotypic complexity concurs with p16INK4a inactivation in TP53-competent immortal endothelial cells.
Wen VW; Wu K; Baksh S; Hinshelwood RA; Lock RB; Clark SJ; Moore MA; Mackenzie KL
Cancer Res; 2006 Nov; 66(22):10691-700. PubMed ID: 17108106
[TBL] [Abstract][Full Text] [Related]
19. Telomere dynamics and telomerase activation in tumor progression: prospects for prognosis and therapy.
Healy KC
Oncol Res; 1995; 7(3-4):121-30. PubMed ID: 8555645
[TBL] [Abstract][Full Text] [Related]
20. A role for the Rb family of proteins in controlling telomere length.
García-Cao M; Gonzalo S; Dean D; Blasco MA
Nat Genet; 2002 Nov; 32(3):415-9. PubMed ID: 12379853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
